Research

=[|Linus Pauling Institute] [|Micronutrient Research for Optimum Health]=
 * [|Vitamin E]
 * [|Function]
 * [|Deficiency]
 * [|The RDA]
 * [|Disease Prevention]
 * [|Disease Treatment]
 * [|Sources]
 * [|Safety]
 * [|LPI Recommendation]
 * [|References]
 * [|Vitamins]
 * [|Minerals]
 * [|Other Nutrients]
 * [|Foods]
 * [|Phytochemicals]
 * [|Glossary]
 * [|Relevant Links]
 * [|Nutrient Index]
 * [|Disease Index]
 * [|Micronutrients for Older Adults]
 * [|Micronutrient Information Center Home]
 * [|LPI Home]
 * [|LPI Home]

Search this site only.

Vitamin E
The term vitamin E describes a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-). Alpha-tocopherol is the only form of vitamin E that is actively maintained in the human body and is therefore, the form of vitamin E found in the largest quantities in the blood and tissue [|(1)]. Because alpha-tocopherol is the form of vitamin E that appears to have the greatest nutritional significance, it will be the primary topic of the following discussion. It is also the only form that meets the latest Recommended Dietary Allowance ([|RDA]) for vitamin E. **Function** The main function of alpha-tocopherol in humans appears to be that of an [|antioxidant]. [radical|Free radicals] are formed primarily in the body during normal metabolism and also upon exposure to environmental factors such as cigarette smoke or pollutants. Fats, which are an integral part of all cell membranes, are vulnerable to destruction through oxidation by free radicals. The fat-soluble vitamin, alpha-tocopherol, is uniquely suited to intercepting free radicals and preventing a chain reaction of lipid destruction. Aside from maintaining the integrity of cell membranes throughout the body, alpha-tocopherol also protects the fats in low density lipoproteins ([|LDLs]) from oxidation. Lipoproteins are particles composed of lipids and proteins, which are able to transport fats through the blood stream. LDLs transport cholesterol from the liver to the tissues of the body. Oxidized LDLs have been implicated in the development of cardiovascular diseases (See [|Disease Prevention]). When a molecule of alpha-tocopherol neutralizes a free radical, it is altered in such a way that its antioxidant capacity is lost. However, other antioxidants, such as vitamin C, are capable of regenerating the antioxidant capacity of alpha-tocopherol [|(2)]. Several other functions of alpha-tocopherol have been identified, which likely are not related to its antioxidant capacity. Alpha-tocopherol is known to inhibit the actvity of protein kinase C, an important [signaling|cell signaling] molecule, as well as to affect the expression and activity of immune and inflammatory cells. Additionally, alpha-tocopherol has been shown to inhibit [|platelet] aggregation and to enhance [|vasodilation] [|(3, 4)]. The function of gamma-tocopherol in humans is presently unclear. Although the most common form of vitamin E in the American diet is gamma-tocopherol (see [|Food Sources]), blood levels of gamma-tocopherol are generally ten times lower than those of alpha-tocopherol. This phenomenon appears due to the action of the alpha-tocopherol transfer protein (a-TTP) in the liver, which preferentially incorporates alpha-tocopherol into lipoproteins that are circulated in the blood [|(1)] and ultimately deliver alpha-tocopherol to different tissues in the body. See the Linus Pauling Institute Newsletter for more information about [|**a-TTP and vitamin E adequacy**]. Because gamma-tocopherol is initially absorbed in the same manner as alpha-tocopherol, small amounts are detectable in blood and tissue. Products of the metabolism of tocopherols, known as metabolites, can be detected in the urine. More gamma-tocopherol metabolites are excreted in the urine than alpha-tocopherol metabolites, suggesting less gamma-tocopherol is needed for use by the body [|(5)]. Limited research in the test tube and in animals indicates that gamma-tocopherol or its metabolites may play a role in the protection of the body from damage by free radicals [|(6, 7)], but these effects have not been convincingly demonstrated in humans. Recently, concern has been raised regarding the fact that taking alpha-tocopherol supplements lowers gamma-tocopherol levels in the blood. However, no adverse effects of moderate alpha-tocopherol supplementation have been demonstrated, while many benefits have been documented (see [|Disease Prevention] and[| Disease Treatment]). In one recent [study|prospective study], increased plasma gamma-tocopherol levels were associated with a significantly reduced risk of developing prostate cancer, while significant protective associations for increased levels of plasma alpha-tocopherol and toenail selenium were found only when gamma-tocopherol levels were also high [|(8)]. These limited findings, in addition to the fact that taking alpha-tocopherol supplements lower gamma-tocopherol levels in the blood, have led some scientists to call for additional research on the effects of dietary and supplemental gamma-tocopherol on health [|(9)]. For more information see the article, **[|Which Form of Vitamin E, Alpha- or Gamma-Tocopherol, is Better?]** in the Linus Pauling Institute Research Report. **Deficiency** Vitamin E deficiency has been observed in individuals with severe malnutrition, genetic defects affecting the alpha-tocopherol transfer protein, and fat [syndrome|malabsorption syndromes]. For example, children with [fibrosis|cystic fibrosis] or [liver disease|cholestatic liver disease], who have an impaired capacity to absorb dietary fat and therefore fat-soluble vitamins, may develop symptomatic vitamin E deficiency. Severe vitamin E deficiency results mainly in [|neurological] symptoms, including impaired balance and coordination (ataxia), injury to the sensory nerves (peripheral neuropathy), muscle weakness (myopathy), and damage to the retina of the eye (pigmented retinopathy). For this reason, people who develop peripheral neuropathy, ataxia or retinitis pigmentosa should be screened for vitamin E deficiency [|(2)]. The developing nervous system appears to be especially vulnerable to vitamin E deficiency because children with severe vitamin E deficiency from birth, who are not treated with vitamin E, develop neurological symptoms rapidly. In contrast, individuals who develop malabsorption of vitamin E in adulthood may not develop neurological symptoms for 10-20 years. It should be noted that symptomatic vitamin E deficiency in healthy individuals who consume diets low in vitamin E has never been reported [|(10)]. Although true vitamin E deficiency is rare, suboptimal intake of vitamin E is relatively common in the U.S. The National Health and Nutrition Examination Survey III (NHANES III) examined the dietary intake and blood levels of alpha-tocopherol in 16,295 multi-ethnic adults over the age of 18. Twenty seven % of white participants, 41% of African Americans, 28% of Mexican Americans and 32% of the other participants were found to have blood levels of alpha-tocopherol less than 20 micromoles/liter, a value chosen because the literature suggests an increased risk for cardiovascular disease below this level [|(11)]. **The Recommended Dietary Allowance (RDA)** The [|RDA] for vitamin E was previously 8 mg/day for women and 10 mg/day for men. The RDA was revised by the Food and Nutrition Board of the Institute of Medicine in 2000 [|(3)]. This new recommendation was based largely on the results of studies done in the 1950s in men fed vitamin E deficient diets. In a test tube analysis, hydrogen peroxide was added to blood samples and the breakdown of red blood cells, known as hemolysis, was used to indicate vitamin E deficiency. Because hemolysis has also been reported in children with severe vitamin E deficiency, this analysis was considered to be a clinically relevant test of vitamin E status. Importantly, this means that the latest RDA for vitamin E continues to be based on the prevention of deficiency symptoms rather than on health promotion and the prevention of chronic disease. //RRR//-alpha-tocopherol (//d//-alpha-tocopherol)** ||
 * Alpha-tocopherol**
 * Gamma-tocopherol**
 * **The Recommended Dietary Allowance (RDA) for
 * **Life Stage** || **Age** || **Males; mg/day (IU/day)** || **Females; mg/day (IU/day)** ||
 * Infants || 0-6 months || 4 mg (6 IU) || 4 mg (6 IU) ||
 * Infants || 7-12 months || 5 mg (7.5 IU) || 5 mg (7.5 IU) ||
 * Children || 1-3 years || 6 mg (9 IU) || 6 mg (9 IU) ||
 * Children || 4-8 years || 7 mg (10.5 IU) || 7 mg (10.5 IU) ||
 * Children || 9-13 years || 11 mg (16.5 IU) || 11 mg (16.5 IU) ||
 * Adolescents || 14-18 years || 15 mg (22.5 IU) || 15 mg (22.5 IU) ||
 * Adults || 19 years and older || 15 mg (22.5 IU) || 15 mg (22.5 IU) ||
 * Pregnancy || all ages || - || 15 mg (22.5 IU) ||
 * Breastfeeding || all ages || - || 19 mg (28.5 IU) ||

**Disease Prevention** **Cardiovascular disease** The results of at least five large [study|observational studies] suggest that increased vitamin E consumption is associated with decreased risk of myocardial infarction (heart attack) or death from heart disease in both men and women. Each study was a [study|prospective study] which measured vitamin E consumption in presumably healthy people and followed them for a number of years to determine how many of them were diagnosed with, or died as a result of heart disease. In two of the studies, those individuals who consumed more than 7 mg of alpha-tocopherol in food were only approximately 35% as likely to die from heart disease as those who consumed less than 3-5 mg of alpha-tocopherol [|(12, 13)]. Two other large studies found a significant reduction in the risk of heart disease only in those women and men who consumed alpha-tocopherol supplements of at least 100 IU (67 mg of //RRR-//alpha-tocopherol) daily [|(14, 15)]. More recently, several studies have observed plasma or red blood cell levels of alpha-tocopherol to be inversely associated with the presence or severity of carotid [|atherosclerosis] detected using ultrasonography [|(16-19)]. In contrast, intervention studies with vitamin E supplements in patients with heart disease have not shown vitamin E to be effective in preventing heart attacks or death (see [|Disease Treatment]). **Cataracts** [|Cataracts] appear to be formed by the oxidation of proteins in the [|lens] of the eye, which may be prevented by antioxidants such as alpha-tocopherol. To date, ten [study|observational studies] have examined the association between vitamin E consumption and the incidence and severity of cataracts. Of these studies, five found increased vitamin E intake to be associated with protection from cataracts, while five reported no association [|(20, 21)]. A recent intervention trial of a daily antioxidant supplement containing 500 mg of vitamin C, 400 IU of vitamin E, and 15 mg of beta-carotene in 4,629 men and women found that the antioxidant supplement was no different than a placebo in its effects on the development and progression of age-related cataracts over a 7-year period [|(22)]. Another intervention trial found that a daily supplement of 50 mg of synthetic alpha-tocopherol daily (equivalent to 25 mg of //RRR-// alpha-tocopherol) did not alter the incidence of cataract surgery in male smokers [|(23)]. Presently, the relationship between vitamin E intake and the development of cataracts requires further clarification before specific recommendations can be made. **Immune Function** Alpha-tocopherol has been shown to enhance specific aspects of the immune response that appear to decline as people age. For example, 200 mg of synthetic alpha-tocopherol (equivalent to 100 mg of //RRR-//alpha-tocopherol) daily for several months increased the formation of [|antibodies] in response to hepatitis B vaccine and tetanus vaccine in elderly adults [|(24)]. Whether alpha-tocopherol associated enhancements in the immune response actually translate to increased resistance to infections such as the flu (influenza virus) in older adults remains to be determined [|(25)]. **Cancer** Many types of cancer are thought to result from oxidative damage to DNA caused by [radical|free radicals]. The ability of alpha-tocopherol to neutralize free radicals has made it the subject of a number of cancer prevention studies. However, several large [study|prospective studies] have failed to find significant associations between alpha-tocopherol intake and the incidence of lung cancer or breast cancer [|(3)]. A placebo-controlled intervention study designed to look at the effect of alpha-tocopherol supplementation on lung cancer in smokers found a 34% reduction in the incidence of [|prostate] cancer in smokers given supplements of 50 mg of synthetic alpha-tocopherol (equivalent to 25 mg of //RRR-//alpha-tocopherol) daily [|(26)]. Because of these findings a large [design|randomized], [|placebo]-controlled intervention study is currently being conducted to examine the effect of alpha-tocopherol supplementation on prostate cancer risk [|(27)]. **Disease Treatment**  Observational studies have suggested that supplemental alpha-tocopherol might have value in the treatment of cardiovascular disease. For example, a small [|observational] study of men who had previously undergone a [artery bypass graft|coronary artery bypass surgery] found a reduction in the progression of coronary artery [|atherosclerosis] by [|angiography] in those men who took at least 100 IU of alpha-tocopherol (67 mg of //RRR-//alpha-tocopherol) daily [|(28)]. A [design|randomized], [|placebo]-controlled intervention trial in Great Britain (the CHAOS study) found that supplementing heart diseasepatients with either 400 or 800 IU of synthetic alpha-tocopherol (equivalent to 268 or 536 mg of //RRR-//alpha-tocopherol) for an average of 18 months resulted in a dramatic 77% reduction in nonfatal heart attacks. However, total deaths from heart disease were not significantly reduced [|(29)]. Chronic [|renal] dialysis patients are at much greater risk of dying from cardiovascular disease than the general population, and there is evidence that they are also under increased [stress|oxidative stress]. Supplementation of renal dialysis patients with 800 IU of natural alpha-tocopherol (536 mg of //RRR-//alpha-tocopherol) for an average of 1.4 years resulted in a significantly reduced risk of heart attack compared to placebo [|(30)]. In contrast, three other intervention trials failed to find significant risk reductions with alpha-tocopherol supplementation. One study, which was designed mainly to examine cancer prevention, found that 50 mg of synthetic alpha-tocopherol daily (equivalent to 25 mg of //RRR-//alpha-tocopherol) resulted in a non-significant decrease in nonfatal heart attacks in those participants who had had previous heart attacks [|(31)]. However, two other large trials found that daily supplements of 400 IU of natural alpha-tocopherol (equivalent to 268 mg //RRR-//alpha-tocopherol) and 300 mg of synthetic alpha-tocopherol (equivalent to 150 mg of //RRR-//alpha-tocopherol) in individuals with evidence of cardiovascular disease (previous heart attack, stroke, or evidence of vascular disease) did not significantly change the risk of a subsequent heart attack or stroke [|(32, 33)]. The results of several other large intervention trials, which are presently in progress may clarify the role of alpha-tocopherol supplementation in the treatment of cardiovascular disease. A more thorough discussion of the complex issues involved in analyzing the results of recent trials of vitamin E in heart disease can be found in the Fall/Winter 1999 issue of the Linus Pauling Institute Newsletter: [|**Fish Oil, Vitamin E, Genes, Diet, and CHAOS**]. For a discussion of some of the limitations of the HOPE study see the article, **[|Vitamin E: Hope or Hopeless],** in the Spring/Summer 2000 issue of the Linus Pauling Institute Newsletter. **Diabetes mellitus** Alpha-tocopherol supplementation of individuals with [|diabetes] has been proposed because diabetes appears to increase [stress|oxidative stress] and because cardiovascular complications (heart attack and stroke) are among the leading causes of death in diabetics. A recent study found a biochemical marker of oxidative stress to be elevated in diabetic individuals [|(34)]. Supplementation with 600 mg of synthetic alpha-tocopherol daily (equivalent to 300 mg of //RRR-//alpha-tocopherol) for 14 days resulted in a reduction in the oxidative stress marker. Studies of the effect of alpha-tocopherol supplementation on blood [|glucose] control have been contradictory. One study reported improved control of blood glucose levels with supplementation of only 100 IU of synthetic alpha-tocopherol daily (equivalent to 45 mg //RRR-//alpha-tocopherol) [|(35)], while studies using 900 to 1,600 IU of synthetic alpha-tocopherol daily (equivalent to 405 to 720 mg //RRR-//alpha-tocopherol) found either minimal or no improvement, respectively [|(36, 37)]. Although there is reason to suspect that alpha-tocopherol supplementation may be beneficial for individuals with diabetes, evidence from well-controlled clinical trials is lacking. **Dementia (impaired cognitive function)** The brain is particularly vulnerable to oxidative stress, which is thought to play a role in the pathology of neurodegenerative diseases, such as [disease|Alzheimer's disease] [|(38)]. In a large placebo-controlled intervention trial, supplementation of individuals who had moderate neurological impairment with 2,000 IU of synthetic alpha-tocopherol daily for two years (equivalent to 900 mg/day of //RRR-//alpha-tocopherol) resulted in a significant slowing of the progression of Alzheimer's [|dementia] [|(39)]. After Alzheimer's disease, vascular dementia (dementia resulting from strokes) is the most common cause of dementia in the U.S. A case-control study examining risk factors for vascular dementia in elderly Japanese-American men found that supplemental vitamin E and vitamin C intake was associated with a significantly decreased risk of vascular and other types of dementia, but not Alzheimer's dementia [|(40)]. Among those without dementia, vitamin E supplement use was associated with better scores on cognitive tests. Although these findings are promising, further studies are required to determine the role of alpha-tocopherol supplementation in the treatment of Alzheimer's disease and other types of dementia. **Cancer** Cancer cells [|proliferate] rapidly and are resistant to death by [|apoptosis] (programmed cell death). Cell culture studies indicate that the vitamin E ester, alpha-tocopheryl succinate, can inhibit proliferation and induce apoptosis in a number of cancer cell lines [|(41, 42)]. The ester form, alpha-tocopheryl succinate, not alpha-tocopherol, is required to effectively inhibit proliferation or induce cancer cell death [|(43)]. Although the mechanisms for the effects of alpha-tocohpheryl succinate on cancer cells are not yet clear, the fact that the ester form has no [|antioxidant] activity argues against an antioxidant mechanism [|(44)]. Limited data from animal models of cancer indicate that alpha-tocopheryl succinate administered by injection may inhibit tumor growth [|(45-47)], but much more research is required to determine whether alpha-tocopheryl succinate will be a useful [|adjunct] to cancer therapy in humans. Certainly, administration by injection will be necessary for any benefit, because alpha-tocopheryl succinate is cleaved to form alpha-tocopherol in the intestine when taken orally [|(48)]. There is currently no evidence in humans that taking oral alpha-tocopheryl succinate supplements delivers alpha-tocopheryl succinate to tissues. **Sources** **Food sources** Major sources of alpha-tocopherol in the American diet include vegetable oils (olive, sunflower, safflower oils), nuts, whole grains, and green leafy vegetables. All eight forms of vitamin E (alpha-, beta, gamma-, and delta-tocopherols and tocotrienols) occur naturally in foods, but in varying amounts. If you wish to check foods you eat frequently for their nutrient content, search the [|USDA food composition database].
 * **Food** || **Serving** || **Alpha-tocopherol (mg)** || **Gamma-tocopherol (mg)** ||
 * Olive oil || 1 tablespoon || 1.9 || 0.1 ||
 * Soybean oil || 1 tablespoon || 1.2 || 10.8 ||
 * Corn oil || 1 tablespoon || 1.9 || 8.2 ||
 * Canola oil || 1 tablespoon || 2.4 || 4.2 ||
 * Safflower oil || 1 tablespoon || 4.6 || 0.1 ||
 * Sunflower oil || 1 tablespoon || 5.6 || 0.7 ||
 * Almonds || 1 ounce || 7.3 || 0.3 ||
 * Hazelnuts || 1 ounce || 4.3 || 0 ||
 * Peanuts || 1 ounce || 2.4 || 2.4 ||
 * Spinach || ½ cup, raw chopped || 1.8 || 0 ||
 * Carrots || ½ cup, raw chopped || 0.4 || 0 ||
 * Avocado (California) || 1 medium || 3.4 || 0.6 ||

**Supplements** **//Alpha-tocopherol//** The average intake of alpha-tocopherol from food in the U.S. is approximately 9 mg daily for men and 6 mg daily for women, well below the RDA of 15 mg/day of //RRR-//alpha-tocopherol [|(3)]. Many scientists believe it is difficult for an individual to consume more than 15 mg/day of alpha-tocopherol from food alone, without also increasing fat intake above recommended levels. All alpha-tocopherol in food is the form of the [|isomer], //RRR-//alpha-tocopherol. The same is not always true for supplements. Vitamin E supplements generally contain from 100 IU to 1000 IU of alpha-tocopherol. Supplements made from entirely natural sources contain only //RRR-//alpha-tocopherol (also labeled //d-//alpha-tocopherol). //RRR-//alpha-tocopherol is the isomer preferred for use by the body, making it the most [|bioavailable] form of alpha-tocopherol. Synthetic alpha-tocopherol, which is often found in food additives and nutritional supplements, is usually labeled //all-rac-//alpha-tocopherol or //dl-//alpha-tocopherol, meaning that all eight isomers of alpha-tocopherol are present in the mixture. Because half of the isomers of alpha-tocopherol present in //all-rac-//alpha-tocopherol are not usable by the body, synthetic alpha-tocopherol is less bioavailable and only half as potent. To calculate the number of mg of bioavailable alpha-tocopherol present in a supplement, use the following formulas: > IU x 0.67 = mg //RRR//-alpha-tocopherol. > Example: 100 IU = 67 mg > IU x 0.45 = mg //RRR//-alpha-tocopherol. > Example: 100 IU = 45 mg For more information on the [|**Biological Activity of Vitamin E**], see the article by Dr. Maret Traber in the Linus Pauling Institute Newsletter. **//Alpha-tocopheryl succinate and alpha-tocopheryl acetate (alpha-tocopheryl esters)//** Alpha-tocopherol supplements are available in the ester forms, alpha-tocopheryl succinate and alpha-tocopheryl acetate. Tocopherol esters are more resistant to [|oxidation] during storage than unesterified tocopherols. When taken orally, the succinate or acetate [|moiety] is removed from alpha-tocopherol in the intestine. The [|bioavailability] of alpha-tocopherol from alpha-tocopheryl succinate and alpha-tocopheryl acetate is equivalent to that of free alpha-tocopherol. Because international units (IU) for alpha-tocopherol esters are adjusted for molecular weight, the conversion factors for determining the amount of bioavailable alpha-tocopherol provided by alpha-tocopheryl succinate and alpha-tocopheryl acetate are not different than those used for alpha-tocopherol (see [|formulas]) [|(3)]. The ester, alpha-tocopheryl succinate, not alpha-tocopherol, is required to effectively inhibit growth and induce death in cancer cells grown in culture (see [|Disease Treatment: Cancer]). However, there is currently no evidence in humans that taking oral alpha-tocopheryl succinate supplements delivers alpha-tocopheryl succinate to tissues. //**Alpha-tocopheryl phosphates (Ester-E®)**// Despite a six million dollar marketing campaign to launch a supplement containing alpha-tocopheryl phosphates in the U.S. [|(49)], there is currently no evidence that supplements containing alpha-tocopheryl phosphates are more efficiently absorbed or have greater bioavailability in humans than supplements containing alpha-tocopherol. **//Gamma-tocopherol//** Gamma-tocopherol supplements and mixed tocopherol supplements are also commercially available [|(50)]. The amounts of alpha- and gamma-tocopherol vary in mixed tocopherol supplements, so it is important to read the label to determine the amount of each tocopherol present in the supplement. **Safety** **Toxicity** Few side effects have been noted in adults taking supplements of less than 2,000 mg of alpha-tocopherol daily (//RRR-// or //all-rac-//alpha-tocopherol). However, most studies of toxicity or side effects of alpha-tocopherol supplementation have lasted only a few weeks to a few months, and side effects occurring as a result of long-term alpha-tocopherol supplementation have not been adequately studied. The most worrisome possibility is that of impaired blood clotting resulting in an increased likelihood of [|hemorrhage] in some individuals. The Food and Nutrition Board of the Institute of Medicine established a tolerable upper intake level ([|UL]) for alpha-tocopherol supplements, based on the prevention of hemorrhage (see [|table] below). The Board felt that 1,000 mg/day of alpha-tocopherol of any form (equivalent to 1,500 IU/day of //RRR-//alpha-tocopherol or 1,100 IU/day of //all-rac-//alpha-tocopherol) would be the highest dose unlikely to result in hemorrhage in almost all adults [|(3)]. Although only certain [|isomers] of alpha-tocopherol are retained in the circulation, all forms are absorbed, and the liver must break them down and eliminate them. The rationale that any form of alpha-tocopherol (natural or synthetic) that can be absorbed could potentially have adverse effects is the basis for a UL that refers to all forms of alpha-tocopherol. Some physicians recommend that high-dose vitamin E supplementation be discontinued one month before elective surgery to decrease the risk of hemorrhage. Premature infants appear to be especially vulnerable to adverse effects of alpha-tocopherol supplementation, which should be used only under controlled supervision by a pediatrician [|(50)]. Supplementation with 400 IU/day of vitamin E has been found to accelerate the progression of retinitis pigmentosa that is not associated with vitamin E deficiency [|(51)]. **//Vitamin E Supplementation and All-Cause Mortality//** A recent [|meta-analysis] that combined the results of 19 clinical trials of vitamin E supplementation for various diseases, including heart disease, end-stage renal failure and Alzheimer's disease, reported that adults who took supplements of 400 IU/day or more were 6% more likely to die from any cause than those who did not take vitamin E supplements [|(52)]. However, further breakdown of the risk by vitamin E dose and adjustment for other vitamin and mineral supplements revealed that the increased risk of death was statistically significant only at a dose of 2,000 IU/day, which is higher than the [|UL] for adults. Furthermore, three other meta-analyses that combined the results of [controlled trial|randomized controlled trials] designed to evaluate the efficacy of vitamin E supplementation for the prevention or treatment of cardiovascular disease found no evidence that vitamin E supplementation up to 800 IU/day significantly increased or decreased cardiovascular disease mortality or all-cause mortality [|(53-55)]. At present, there is no convincing evidence that vitamin E supplementation up to 800 IU/day increases the risk of death from cardiovascular disease or other causes.  *Source of intake should be from foods or formula only. **Drug interactions** Individuals on anticoagulant therapy (blood thinners) or individuals who are vitamin K deficient should not take alpha-tocopherol supplements without close medical supervision because of the increased risk of hemorrhage [|(3)]. A number of medications may decrease the absorption of vitamin E, including cholestyramine, colestipol, isoniazid, mineral oil, orlistat, sucralfate, and the fat substitute, olestra. Anticonvulsant drugs such as phenobarbitol, phenytoin, or carbamazepine may decrease plasma levels of vitamin E [|(3,] [|50)]. **//Antioxidants and HMG-CoA reductase inhibitors (statins)//** A 3-year [controlled trial|randomized controlled trial] in 160 patients with documented coronary heart disease (CHD) and low [|HDL] levels found that a combination of simvastatin (Zocor) and niacin increased HDL2 levels, inhibited the progression of coronary artery stenosis (narrowing), and decreased the frequency of cardiovascular events, such as [infarction|myocardial infarction] and stroke [|(56)]. Surprisingly, when an antioxidant combination (1000 mg vitamin C, 800 IU alpha-tocopherol, 100 mcg of selenium, and 25 mg beta-carotene daily) was taken with the simvastatin-niacin combination, the protective effects were diminished. However, in a much larger randomized controlled trial of simvastatin and an antioxidant combination (600 mg vitamin E, 250 mg vitamin C, and 20 mg beta-carotene daily) in more than 20,000 men and women with coronary artery disease or diabetes, the antioxidant combination did not adversely affect the cardioprotective effects of simvastatin therapy over a 5-year period [|(57)]. These contradictory findings indicate that further research is needed on potential interactions between antioxidant supplementation and cholesterol-lowering agents, such as HMG-CoA reductase inhibitors (statins). **Linus Pauling Institute Recommendation** Scientists at the Linus Pauling Institute feel there exists credible evidence that taking a supplement of 200 IU of natural source //d//-alpha-tocopherol (//RRR-//alpha-tocopherol) daily with a meal may help protect adults from chronic diseases like heart disease, stroke, neurodegenerative diseases, and some types of cancer. The amount of alpha-tocopherol required for such beneficial effects appears to be much greater than that which could be achieved through diet alone (see [|Sources]). Since supplements containing 200 IU of //d-//alpha-tocopherol are often as expensive as supplements containing 400 IU of //d-//alpha-tocopherol, a less expensive alternative may be to take 400 IU of //d-//alpha-tocopherol every other day. Alpha-tocopherol supplements are unlikely to be absorbed unless taken with food. **Older adults (65 years and older)** The Linus Pauling Institute's recommendation of a supplement providing 200 IU of natural source //d-//alpha-tocopherol daily (or 400 IU of //d-//alpha-tocopherol every other day) with a meal is also appropriate for generally healthy older adults. **[|References]** Written by: Jane Higdon, Ph.D. Linus Pauling Institute Oregon State University Reviewed by: Maret G. Traber, Ph.D. Professor of Nutrition and Exercise Science Principal Investigator, Linus Pauling Institute Oregon State University Last updated 11/11/2004 Copyright 2000-2008 Linus Pauling Institute
 * **//RRR//-alpha-tocopherol (natural or //d//-alpha-tocopherol):**
 * **//all-rac-//alpha-tocopherol (synthetic or //dl//-alpha-tocopherol):**
 * **Tolerable Upper Intake Level (UL) for Alpha-Tocopherol** ||
 * **Age Group** || **mg/day (IU/day //d//-alpha-tocopherol)** ||
 * Infants 0-12 months || Not Possible to Establish* ||
 * Children 1-3 years || 200 mg (300 IU) ||
 * Children 4-8 years || 300 mg (450 IU) ||
 * Children 9-13 years || 600 mg (900 IU) ||
 * Adolescents 14-18 years || 800 mg (1,200 IU) ||
 * Adults 19 and older || 1,000 mg (1,500 IU) ||

**Disclaimer** The Linus Pauling Institute Micronutrient Information Center provides scientific information on health aspects of micronutrients and phytochemicals for the general public. The information is made available with the understanding that the author and publisher are not providing medical, psychological, or nutritional counseling services on this site. The information should not be used in place of a consultation with a competent health care or nutrition professional. The information on micronutrients and phytochemicals contained on this Web site does not cover all possible uses, actions, precautions, side effects, and interactions. It is not intended as medical advice for individual problems. Liability for individual actions or omissions based upon the contents of this site is expressly disclaimed.|| ||  ||  ||  || Heading 1Heading 2Heading 3Heading 4Heading 5Heading 6NormalCode ||  ||  ||  ||  ||  ||  ||  ||  ||  ||  ||  ||  ||  || Cancel || none //Optional:// a note about this edit for the page history log

//Optional:// tags for this page, separated by commas enabledEditButton enabledEditButton
 * Cancel ||
 * Note** that the content you create on http://collabowiki.wikispaces.com is licensed under the [|Creative Commons Attribution Share-Alike 3.0 License]. Please only submit content that you write yourself or that is in the public domain. Learn more about our open content policy.

Insert a File
Double click an image or file to insert it into the page. Double clicking a file: inserts the file links to the file==Upload New File ==
 * Show: || All MediaImagesOther Files [[image:http://c1.wikicdn.com/i/c.gif width="18" height="18" caption="please wait..."]] ||
 * Page: ||  ||
 * Jump: || A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ||

Insert External Image by URL
Enter an external image address, click "Load", then double click the image to insert it into the page. Choose the kind of content you would like to embed: =Embed a Table of Contents= **About the Table of Contents** The Table of Contents will create a set of links to jump to sections on this page. Create sections by adding section headings and they will automatically be added to the Table of Contents =Embed the Contents of a Wiki Page= **About Including Pages** The contents of another wiki page can be included inside this page. When the other page is updated, the changes will be reflected on this page. || Page Name || || =Embed a List of Pages=
 * * [[image:http://c1.wikicdn.com/i/c.gif caption="Wikispaces" link="Elizabeth and Lauren J.#widget-wikispaces"]] Wikispaces
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Video" link="Elizabeth and Lauren J.#widget-video"]] Video
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Audio" link="Elizabeth and Lauren J.#widget-audio"]] Audio
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Calendar" link="Elizabeth and Lauren J.#widget-calendar"]] Calendar
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Spreadsheet" link="Elizabeth and Lauren J.#widget-spreadsheet"]] Spreadsheet
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Document" link="Elizabeth and Lauren J.#widget-document"]] Document
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Polls" link="Elizabeth and Lauren J.#widget-poll"]] Polls
 * [[image:http://c1.wikicdn.com/i/c.gif caption="RSS Feed" link="Elizabeth and Lauren J.#widget-rss"]] RSS Feed
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Chat and IM" link="Elizabeth and Lauren J.#widget-chat"]] Chat and IM
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Slideshow" link="Elizabeth and Lauren J.#widget-slideshow"]] Slideshow
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Map" link="Elizabeth and Lauren J.#widget-map"]] Map
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Bookmark" link="Elizabeth and Lauren J.#widget-bookmark"]] Bookmark
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Other HTML" link="Elizabeth and Lauren J.#widget-custom"]] Other HTML || Choose the category of application you would like to embed from the list on the left.
 * Table of Contents
 * RSS Feed
 * Contents of a Wiki Page
 * List of Wiki Pages
 * Discussion Area
 * Page History
 * List of Links to This Page
 * Tag Cloud
 * Top Contributors
 * Other
 * Title ||  ||
 * Editable ||  ||
 * Wrap ||  ||

**About Including Page Lists** A page list includes links to all pages in this Wikispace. This is useful for adding to navigation sections. || Show Pages Tagged || || =Embed a Discussion Area=
 * Move //Home// Page to Top ||  ||

=Embed the History of This Page=
 * Page Name || [[image:http://collabowiki.wikispaces.com/i/error_add.png]] ||
 * Number of Comments ||  ||

=Embed Links to this Page=
 * Page Name || [[image:http://collabowiki.wikispaces.com/i/error_add.png]] ||
 * Number of Revisions ||  ||

=Embed a Tag cloud=
 * Number of Links ||  ||

**About the Tag Cloud** The tag cloud is a visual representation of the tags on your wiki pages. More commonly used tags are shown with more emphasis. Hover over the tag to see how many occurrences there are in your Wikispace, and click the tag to get a list of pages with that tag. =Embed a Top Contributors List= Choose the type of video you would like to embed: Choose the type of audio you would like to embed: Choose the type of calendar you would like to embed: Choose the type of spreadsheet you would like to embed: Choose the type of document you would like to embed: Choose the type of poll you would like to embed: Choose the type of chat application you would like to embed: Choose the type of slideshow you would like to embed: Choose the type of map you would like to embed: Choose the type of bookmark you would like to embed: =YouTube= > =Google Video= > > > =Yahoo Video= > =TeacherTube= > =Blip.TV= > > > =Odeo= > =imeem= > =Google Calendar= > > > > > Your Google Calendar ID: =Airset= > > =30 Boxes= > > =NumSum= > > =Edit Grid= > > =Google Spreadsheet= > > > > > > =Scribd= > =Bitty Browser= Enter the URL of the Web Page that you want to embed on your Wikispaces page:
 * Days ||  ||
 * Image Size || SmallLarge ||
 * Show Username || YesNo ||
 * [[image:http://c1.wikicdn.com/i/c.gif caption="YouTube" link="Elizabeth and Lauren J.#widget-youtube"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="TeacherTube" link="Elizabeth and Lauren J.#widget-teachertube"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Google Video" link="Elizabeth and Lauren J.#widget-google"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Yahoo Video" link="Elizabeth and Lauren J.#widget-yahoo"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="BlipTV" link="Elizabeth and Lauren J.#widget-bliptv"]]
 * Other
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Odeo" link="Elizabeth and Lauren J.#widget-odeo"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="imeem" link="Elizabeth and Lauren J.#widget-imeem"]]
 * Other
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Google Calendar" link="Elizabeth and Lauren J.#widget-googlecalendar"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Airset" link="Elizabeth and Lauren J.#widget-airset"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="30 Boxes" link="Elizabeth and Lauren J.#widget-thirtyboxes"]]
 * Other
 * [[image:http://c1.wikicdn.com/i/c.gif caption="NumSum" link="Elizabeth and Lauren J.#widget-numsum"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Edit Grid" link="Elizabeth and Lauren J.#widget-editgrid"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Google Spreadsheet" link="Elizabeth and Lauren J.#widget-googlespreadsheet"]]
 * Other
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Scribd" link="Elizabeth and Lauren J.#widget-scribd"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="BittyBrowser" link="Elizabeth and Lauren J.#widget-bittybrowser"]]
 * Other
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Survey Gizmo" link="Elizabeth and Lauren J.#widget-surveygizmo"]]
 * Other
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Gabbly" link="Elizabeth and Lauren J.#widget-gabbly"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Skype" link="Elizabeth and Lauren J.#widget-skype"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Yack Pack" link="Elizabeth and Lauren J.#widget-yackpack"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Meebo" link="Elizabeth and Lauren J.#widget-meebo"]]
 * Other
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Slide" link="Elizabeth and Lauren J.#widget-slide"]]
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Flickr" link="Elizabeth and Lauren J.#widget-flickr"]]
 * Other
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Google Maps" link="Elizabeth and Lauren J.#widget-googlemap"]]
 * Other
 * [[image:http://c1.wikicdn.com/i/c.gif caption="Delicious" link="Elizabeth and Lauren J.#widget-delicious"]]
 * Other
 * 1) Go to the video on [|YouTube.com] that you want to embed
 * 2) Look for the **"Embed"** field on the video page
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the video or click **Save**
 * 1) Go to the video on [|video.google.com] that you want to embed
 * 2) Click the **"Email - Blog - Post to MySpace"** button on the video page
 * 1) Click the **"Embed HTML"** link
 * 1) Copy the text from the shown box into the box below
 * 1) Click **Preview** to preview the video or click **Save**
 * 1) Go to the video on [|video.search.yahoo.com] that you want to embed
 * 2) Look for the **"Add to Site"** field on the video page
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the video or click **Save**
 * 1) Go to the video on [|TeacherTube.com] that you want to embed
 * 2) Look for the **"Embeddable"** field on the video page
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the video or click **Save**
 * 1) Go to the video on [|blip.tv] that you want to embed
 * 2) Click the **"Share"** button at the bottom of the video
 * 1) Click the **"embed"** tab at the bottom of the dialog box
 * 1) Copy the text fro the shown box into the box below
 * 1) Click **Preview** to preview the video or click **Save**
 * 1) Go to the recording on [|odeo.com] that you want to embed
 * 2) Click the **"Embeddable Player"** link on the recording page
 * 1) Copy the text from the box next to the player you want to use into the box below
 * 2) Click **Preview** to preview the recording or click **Save**
 * 1) Go to the playlest on [|imeem.com] that you want to embed
 * 2) Look for the **"Embed in your Blog, Website, etc:"** field on the playlist page
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the playlist or click **Save**
 * 1) Go to your [|Google Calendar]
 * 2) Click **"Manage calendars"**
 * 1) Click **"Share this calendar"** next to the name of the calendar that you want to share
 * 1) Ensure that your calendar is being shared
 * 1) Click **"Calendar Details"**
 * 1) Copy the text next to **"Calendar ID"** into the box below
 * 1) Click **Preview** to preview the calendar or click **Save**
 * 1) Go to any [|Airset] group calendar
 * 2) Under the **"Calendar"** menu, select **"Publish..."**
 * 1) Click **"Publish this Calendar"** and follow the instructions to publish
 * 2) Under the **"Calendar"** menu, select **"Publish..."** again
 * 3) Look for the text field under **"Embed this Calendar in your own Web Page"**
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the calendar or click **Save**
 * 1) Go to any [|30 Boxes] calendar
 * 2) Under the **"SHARE"** menu, select **"Add To Blog"**
 * 1) Look for the text field under **"EMBED CALENDAR (WIDE: 800px)"**
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the calendar or click **Save**
 * 1) Go to any [|NumSum] spreadsheet
 * 2) Under the **"File"** menu, select **"Publish to my blog"**
 * 1) Look for the text field on the page shown
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the spreadsheet or click **Save**
 * 1) Go to any [|EditGrid] spreadsheet
 * 2) Under the **"Publish"** menu, select **"Post to Blog / Webpage..."**
 * 1) Set your options to suit your needs
 * 2) Look for the text field next to **"Copy the Code Segment"**
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the spreadsheet or click **Save**
 * 1) Go to any [|Google Spreadsheet]
 * 2) Click **"Publish"** tab at the upper-right of the spreadsheet edit page
 * 1) Click **"Publish now."**
 * 1) Click **"More publishing options.."**
 * 1) In the new window select **"HTML to embed in a webpage"** in the **"File formats"** dropdown menu
 * 1) Click **"Generate URL"**
 * 1) Copy the text under **"Here's the code:"** into the box below
 * 1) Click **Preview** to preview the spreadsheet or click **Save**
 * 1) Go to any [|scribd.com] document
 * 2) Look for the **"Embed"** text box
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the document or click **Save**

=Survey Gizmo= > > > =RSS Feed= **About RSS Feeds** A feed is a specially formatted web page that lists a summary of each change on a site, sorted by date. Sometimes you'll see feeds called syndication, XML, or RSS - they're all the same thing. || Feed URL || || =Skype=
 * 1) Go to any [|Survey Gizmo] survey
 * 2) Click the **"Publishing"** tab
 * 1) If you have not published your survey, click **"Launch Your Survey Now"**
 * 1) Look for the text box under **"Option 1 - the iFrame Option:"**
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the document or click **Save**
 * Number of Entries || 1234567891011121314151617181920 ||
 * Show Description || length: ||
 * Show Link ||  ||
 * Show Date ||  ||
 * Show Author ||  ||
 * Show Audio and Video ||  ||

> =Gabbly= =YackPack= Your Walkie Talkie Web Channel: =Meebo= > > > =Slide= > =Flickr= > Feed URL: =Del.icio.us= > =Google Maps= > > Add your favorite media clips and applications to your Wikispace in three easy steps:
 * 1) Go to the [|Skype button page]
 * 2) Enter your Skype Name and select your button style
 * 3) Look for the text box under **"Copy & paste this code"**
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the chat or click **Save**
 * 1) Go to [|meebome.com]
 * 2) Fill out the form and click **"next"**
 * 1) Login to your meebo account or create a new meebo account and click **"next"**
 * 1) Look for the text box under **"Congratulations! Here's the code you need..."**
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the chat or click **Save**
 * 1) Go to any [|Slide] slideshow
 * 2) Look for the text box next to **"Embed"**
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the chat or click **Save**
 * 1) Go to any [|Flickr] user or tag page
 * 2) Copy the URL pointed to by the **"Latest"** link next to **"Subscribe to"** at the bottom of the page
 * 1) Paste that URL into that box below
 * 2) Click **Preview** to preview the slideshow or click **Save**
 * 1) Go to your [|del.icio.us] account
 * 2) Click **"settings"** at the top right
 * 3) Click **"link rolls"** under the **"Blogging"** menu at the right
 * 4) Look for the text box under **"Linkrolls"**>
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the chat or click **Save**
 * 1) Go to your [|Google Map]
 * 2) Click **"Link to this page"**
 * 1) Look for the text box under **"Paste HTML to embed in website"**
 * 1) Copy the text from that box into the box below
 * 2) Click **Preview** to preview the map or click **Save**
 * 1) Go to your favorite video clip, podcast, or embedded application. Anything from **Google Calendar** to **Odeo** to **YouTube**!
 * 2) Find the HTML code to paste into your site. This will be found in a text box labeled "Embed", "Embed HTML", "Add to My Site/Blog", "Link to this page", or similar.
 * 3) Paste in the HTML below and click "Preview" to see how it will look. When you save your changes by clicking the "Save" button, your media clip or application will appear in your Wikispaces page.

|| =Other users editing this page=

=Changes since you started editing= Paste the code fragment into the text area
 * None
 * Format: Plain Text ActionscriptAdaApache configuration fileApplescriptx86 AssemblerActive Server PagesAutoIt Window automation scriptBourne Again ShellBasic4GLBlitz BasicBNF: Backus-Naur formCContext-Free Design GrammarColdfusionC++C#Cascading Style SheetsDelphi Object PascalDiffDivDOSD programming languageEiffelFree BasicFortranGame Maker LanguageGroovyHTMLUno IDLINJInno Script Object PascalIOJavaJava, version 5 syntaxJavascriptLaTeXLispLuaMatlabmIRCMySQL SQLOracle SQLObjective CamlPascalPERLPHPPythonQBasicMicrosoft Registryrobots.txtRubySASSchemesdlbasicSmalltalkSmarty PHP template languageSQLTCLThinbasicTransact-SQLVisual BasicVisual Basic .NETVHSICADL, very high speed integrated circuit HDLVisual Fox ProWindows Batch ScriptingXML

or Cancel==Basic Mode== Switch to Advanced==Advanced Mode== Switch to Basic

You can apply any CSS style below in the standard CSS format, e.g. //font-face: Arial, Helvetica; color: red;// Alignment: NoneLeftCenterRight Link: Change Link · Remove Link Add Link Caption: * Choose the number of columns and rows that the table will contain. Columns: Rows: or Cancel || Help · About · Blog · Terms · Privacy · [|**Support**] · [|**Upgrade**]Contributions to http://collabowiki.wikispaces.com are licensed under a [|Creative Commons Attribution Share-Alike 3.0 License]. Portions not contributed by visitors are Copyright 2008 Tangient LLC.Loading...
 * Font || Select a Font...ArialArial BlackComic Sans MSCourier NewGeorgiaImpactLucida ConsoleLucida Sans UnicodePalatino LinotypeTahomaTimes New RomanTrebuchet MSVerdanaSymbolWebdings ||
 * Size || [[image:http://c2.wikicdn.com/i/minus.png width="20" height="20" caption="-" link="Elizabeth and Lauren J.#"]] [[image:http://c1.wikicdn.com/i/plus.png width="20" height="20" caption="+" link="Elizabeth and Lauren J.#"]] ||
 * Color ||  ||
 * Background Color ||  ||
 * Alignment || Select Alignment...LeftCenterRight ||
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * Left
 * Right
 * Center
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * Merge To The Left
 * Merge To The Right
 * Split Merged Cells
 * Make Header
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * Left
 * Right
 * Center
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * Add above
 * Add below
 * Remove Row
 * Make Header
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * Left
 * Right
 * Center
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * Add to the left
 * Add to the right
 * Remove Column
 * Make Header
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * [[image:http://collabowiki.wikispaces.com/i/bullet_arrow_down.gif width="15" height="15" link="Elizabeth and Lauren J.#"]]
 * Left
 * Right
 * Center
 * Remove Table